Biotech Conference 2005- Biotechnology & Life Science Global Venture Congress 2005, Madison Square Garden, New York

The Biotech & Life Sciences Global Venture Congress™ conference is designed to explore the frontiers of biotech & life sciences, address the venture capital landscape, and discover cutting-edge Biotech and Life Sciences companies. A “one-of-a-kind conference” meant for those great minds, visionaries & entrepreneurs who want to do someting different, something extraordinary...something great.

Highlights
_____________________________

Two Nobel Laureate plenary sessions, six (6) panel discussions, 25+ Distinguished Speakers, two(2) innovative company presentation sessions, exclusive networking breaks, excellent menu, premium wine/beer selections, and a private VIP cocktail reception.

Delegates

Registered Delegates Click Here To Get Answer to FAQ
_____________________________

President/CEO - Digital Bio (South Korea); CEO - Med Discovery (Switzerland); Director - Exgenis (UK); CEO - Congenix (Russia); Managing Director- The Carlyle Group; Professor Of Medicine- Columbia University; Partner - Phillips Nizer, LLP; Biotech Executive - Microsoft; President & CEO- Serenex, Inc.; President & CEO- BioTrove; President & COO- Pharmos Corporation; Principal- The Aurora Funds; Principal- Cannon Design; Principal- Bear Stearns Health Innoventures; Biotech Entrepreneur (M.D., Ph.D) - Harvard Medical School; Tech. Advisor & Patent Agent- Stroock & Stroock & Lavan; Sr. Vice President- Life Sciences Greenhouse; Sr. Vice President- William Gallagher Associates; VP of Research & Development/ CSO- Locus Pharmaceuticals, Inc; VP, Business Development- Chugai Pharma USA; Vice President- Cytel Inc.; and more...

Presenting Companies
_____________________________

Serenex- Drug discovery and drug development company with drugs in Pre-clinical trials and Phase II.. So far it has raised over $25 million and is seeking $30 million in Series C funding. (raised $30M )
Locus Pharmaceuticals - Computational drug design and drug development company expected to file 3 INDs within the next year. Has raised $87.8 million and is currently seeking an additional $25 million.
Transave, Inc.- Raised $17.824M
Company C - Company developing topical products for viral, fungal, and bacterial infections. Have completed several Phase I and Phase II trials. So far has raised $2.6 million and is currently seeking $15 million.
and more...
Click here to see details and apply now.

Speakers
_____________________________

Speakers at the conference are world renowned visionaries, carefully chosen active investors in Biotech and Life Sciences companies, founders/C-level executives of cutting edge Biotech companies and renowned thought leaders, movers and shakers of the biotech industry and analysts. More than 25 speakers already confirmed. Click here to see confirmed speakers.